{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001682","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.208741+00:00","generated_at":"2026-05-28T05:04:31.167558+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Evofem receives OTCQB delisting notice for trading below $0.01 for 30 days; 90-day cure period until April 6, 2025","bullets":["Received OTC notice on Jan 6, 2025: closing bid price below $0.01 for 30 consecutive days violates Minimum Bid Price Requirement.","Has 90-day compliance period until April 6, 2025 to regain compliance by having bid price >= $0.01 for 10 consecutive trading days.","Failure to regain compliance by April 6, 2025 will result in removal of common stock from OTCQB.","Company says it will monitor bid price and consider available options to resolve deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001682","json":"https://secwatch.observer/filing/0001493152-25-001682.json","markdown":"https://secwatch.observer/filing/0001493152-25-001682.md","text":"https://secwatch.observer/filing/0001493152-25-001682.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/0001493152-25-001682-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T05:04:31.167558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9638f12d1bb9a543f315403f7508420bc3b7a158","claim":"Evofem Biosciences, Inc. received a otc deficiency notice notice regarding minimum bid price.","evidence_excerpt":"January 6, 2025, Evofem Biosciences, Inc. (the “Company”) received a written notice (the “OTC Notice”) from the OTC Markets Group (“OTC”) notifying the Company that, because the closing bid price for the Company’s common","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/0001493152-25-001682-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"otc"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}